CysVac2

N/A

Report date: 2025/03/19 11:39:36

Base Information

Drug NameCysVac2

Drug Alias NameMycobacterium tuberculosis fusion protein vaccine (University of Sydney/Centenary Institute)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity of Sydney

China Registration ClassN/A

Develop Information

Active CompaniesCentenary Institute Cancer Medicine & Cell Biology University of Sydney

Inactive CompaniesN/A

Active IndicationsTuberculosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A